SCHEMBL4543756

SCHEMBL4543756

O=C(NCc1ccc(OC(F)(F)F)c(Cl)c1)c1cccn1-c1ncc(Cl)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
PPARG P37231 1/20 0.53
KMT2A Q03164 1/20 0.53
NR2E3 Q9Y5X4 1/20 0.53
NCOR2 Q9Y618 1/20 0.53
SCN3A Q9NY46 6/20 0.47
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SCN1A P35498 2/20 0.43
SCN5A Q14524 2/20 0.43
SCN9A Q15858 2/20 0.43
SCN2A Q99250 2/20 0.43
SCN8A Q9UQD0 2/20 0.43
SCN10A Q9Y5Y9 2/20 0.43
KCNH2 Q12809 1/20 0.43
ROCK2 O75116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4540218 0.91 MEN1 (0.65) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4539445 0.89 MEN1 (0.54) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4541439 0.85 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4540017 0.84 MEN1 (0.65) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4538848 0.84 SCN3A (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4542661 0.82 MEN1 (0.58) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4540452 0.81 MEN1 (0.54) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4539824 0.81 MEN1 (0.47) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4544058 0.81 MEN1 (0.59) MEN1PPARGKMT2ANR2E3NCOR2
SCHEMBL4544004 0.80 MEN1 (0.67) MEN1PPARGKMT2ANR2E3NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed